Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 15, 2025

Primary Completion Date

May 15, 2026

Study Completion Date

June 15, 2026

Conditions
Oral Lichen Planus
Interventions
DIETARY_SUPPLEMENT

Topical Bromelain

A natural enzyme-based formulation derived from pineapple, bromelain in orabase is being investigated for its anti-inflammatory and wound-healing properties. As a non-steroidal alternative, it offers a potentially safer treatment option with minimal side effects.

DRUG

0.1% topical triamcinolone acetonide

A corticosteroid-based standard treatment for OLP, triamcinolone acetonide in orabase is used for its strong anti-inflammatory and immunosuppressive effects. It serves as the conventional treatment versus novel therapy in this study

COMBINATION_PRODUCT

Combination of Topical Bromelain and Triamcinolone Acetonide in Orabase

This novel formulation combines the enzymatic, healing properties of bromelain with the anti-inflammatory property of triamcinolone. It is designed to provide enhanced therapeutic effects through synergistic action, potentially reducing the required corticosteroid dose while improving clinical outcomes.

All Listed Sponsors
lead

Cairo University

OTHER